Dimitri E. Grigoriadis
CIK 1423838 · Chief Research Officer · last filed 2022-02-02
Dimitri E. Grigoriadis is a Chief Research Officer who has filed 74 SEC Form 4 insider transactions across 1 company since 2008. The most recent filing, for NBIX, was dated Feb 2, 2022. Across all open-market trades the lifetime net is −$52.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $11.7M across reported positions. 75 SEC filings were submitted jointly with NEUROCRINE BIOSCIENCES INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
NBIX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SAN DIEGO, CA 92130
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NBIX | Chief Research Officer | 82,273 | $142.44 | $11.72M | -$52.77M | 74 | 2022-02-02 |
Recent Filings
74 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-02-02 | NBIX | Grant (A) | — | $0 | EDGAR |
| 2021-10-12 | NBIX | Mixed | −3,000 | -$622.3K | EDGAR |
| 2021-03-29 | NBIX | Grant (A) | — | $0 | EDGAR |
| 2021-02-09 | NBIX | Mixed | −3,313 | -$384.8K | EDGAR |
| 2020-11-16 | NBIX | Sell (S) | −2,257 | -$204.8K | EDGAR |
| 2020-08-07 | NBIX | Sell (S) | −2,257 | -$268.2K | EDGAR |
| 2020-06-15 | NBIX | Exer (M) | +5,571 | $200.0K | EDGAR |
| 2020-05-20 | NBIX | Mixed | −32,749 | -$5.89M | EDGAR |
| 2020-05-11 | NBIX | Sell (S) | −8,682 | -$915.5K | EDGAR |
| 2020-04-28 | NBIX | Sell (S) | −1,934 | -$192.3K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.